Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Solid Tumor × Docetaxel × Clear all

Phase

Phase 1 8 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 201 Carcinoma, Non-Small-Cell Lung 174 Prostatic Neoplasms 122 Lung Neoplasms 79 Stomach Neoplasms 73 Squamous Cell Carcinoma of Head and Neck 50 Head and Neck Neoplasms 45 Neoplasms 34 Neoplasm Metastasis 31 Esophageal Neoplasms 31 Pancreatic Neoplasms 25 Ovarian Neoplasms 23 Sarcoma 17 Triple Negative Breast Neoplasms 16 Carcinoma, Squamous Cell 16 Adenocarcinoma of Lung 16 Urinary Bladder Neoplasms 14 Nasopharyngeal Carcinoma 13 Adenocarcinoma 12 Recurrence 11 Adenocarcinoma Of Esophagus 11 Carcinoma, Transitional Cell 9 Carcinoma, Ovarian Epithelial 9 Inflammatory Breast Neoplasms 8 Breast Neoplasms, Male 8 Leiomyosarcoma 7 Esophageal Squamous Cell Carcinoma 7 Uterine Cervical Neoplasms 6 Nasopharyngeal Neoplasms 6 Laryngeal Neoplasms 6

Interventions

apatinib 3 vistusertib 2 olaparib 2 camrelizumab 2 atezolizumab 2 Ipilimumab 2 Everolimus 2 trametinib 1 tilsotolimod 1 tazemetostat 1 tazarotene 1 spartalizumab 1 sargramostim 1 sacituzumab govitecan 1 rucaparib 1 roniciclib 1 romiplostim 1 pyrotinib 1 phosphorylethanolamine 1 pemigatinib 1 pembrolizumab 1 pazopanib 1 palbociclib 1 niraparib 1 magrolimab 1 lenvatinib 1 irinotecan sucrosofate 1 famitinib 1 dalpiciclib 1 dabrafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04827576 2025-05-08

ELEVATELung&UC

Gilead Sciences

Phase 2 Terminated

106 enrolled 22 charts

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡